Garrison Bradford & Associates Inc Vista Gen Therapeutics, Inc. Call Options Transaction History

Garrison Bradford & Associates Inc

  • $100 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding VTGN

# of Institutions
2
Shares Held
2.7M
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $666M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Garrison Bradford & Associates Inc Portfolio

Follow Garrison Bradford & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Bradford & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Bradford & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email